A new trading day began on Friday, with EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock price up 17.93% from the previous day of trading, before settling in for the closing price of $11.88. EYPT’s price has ranged from $3.91 to $13.98 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 15.65% over the past five years. Meanwhile, its annual earnings per share averaged -29.54%. With a float of $60.27 million, this company’s outstanding shares have now reached $68.89 million.
EyePoint Pharmaceuticals Inc (EYPT) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of EyePoint Pharmaceuticals Inc is 12.56%, while institutional ownership is 89.93%. The most recent insider transaction that took place on May 19 ’25, was worth 29,950. In this transaction Director of this company bought 5,000 shares at a rate of $5.99, taking the stock ownership to the 36,500 shares. Before that another transaction happened on May 16 ’25, when Company’s Director bought 5,000 for $5.81, making the entire transaction worth $29,050. This insider now owns 31,500 shares in total.
EyePoint Pharmaceuticals Inc (EYPT) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.54 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.75 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -29.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.62% during the next five years compared to 15.65% growth over the previous five years of trading.
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Trading Performance Indicators
Here are EyePoint Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.68, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -3.02 in one year’s time.
Technical Analysis of EyePoint Pharmaceuticals Inc (EYPT)
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) saw its 5-day average volume 0.82 million, a positive change from its year-to-date volume of 0.8 million. As of the previous 9 days, the stock’s Stochastic %D was 77.17%.
During the past 100 days, EyePoint Pharmaceuticals Inc’s (EYPT) raw stochastic average was set at 96.10%, which indicates a significant increase from 89.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.74 in the past 14 days, which was higher than the 0.63 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.68, while its 200-day Moving Average is $8.03. Nevertheless, the first resistance level for the watch stands at $14.98 in the near term. At $15.96, the stock is likely to face the second major resistance level. The third major resistance level sits at $17.54. If the price goes on to break the first support level at $12.42, it is likely to go to the next support level at $10.84. Assuming the price breaks the second support level, the third support level stands at $9.86.
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Key Stats
With a market capitalization of 965.67 million, the company has a total of 68,927K Shares Outstanding. Currently, annual sales are 43,270 K while annual income is -130,870 K. The company’s previous quarter sales were 5,330 K while its latest quarter income was -59,430 K.
